Immatics N.V. (IMTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 10.81 |
| Open | 10.88 |
| Bid | 10.85 x 200 |
| Ask | 10.92 x 400 |
| Day's Range | 10.73 - 11.02 |
| 52 Week Range | 7.15 - 13.16 |
| Volume | |
| Avg. Volume | 428,555 |
| Market Cap | 1.122B |
| Beta (5Y Monthly) | 0.68 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.28 |
| Earnings Date | May 14, 2024 - May 20, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.66 |
GlobeNewswireImmatics Announces Full Year 2023 Financial Results and Corporate Update
Interim clinical data update on ACTengine® IMA203 GEN1 (PRAME) in melanoma at RP2D in November 2023: 50% confirmed objective response rate with median duration of response not reached at median follow-up of 14.4 months; IMA203 was well toleratedRegistration-enabling randomized Phase 2/3 trial for ACTengine® IMA203 GEN1 in 2L+ melanoma planned to begin in 2024 Next data update on IMA203 GEN1 and IMA203CD8 GEN2 planned for 2H 2024 First clinical data updates for Immatics’ next-generation TCR Bispe
Simply Wall St.With 52% institutional ownership, Immatics N.V. (NASDAQ:IMTX) is a favorite amongst the big guns
Key Insights Institutions' substantial holdings in Immatics implies that they have significant influence over the...
- Simply Wall St.
Immatics' (NASDAQ:IMTX) investors will be pleased with their notable 35% return over the last year
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But if you pick...
© 2024 Yahoo. All rights reserved.